Loading...

Aspen Pharmacare Holdings Limited

APNHFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$7.25
$0.00(0.00%)

Aspen Pharmacare Holdings Limited (APNHF) Company Profile & Overview

Explore Aspen Pharmacare Holdings Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Aspen Pharmacare Holdings Limited (APNHF) Company Profile & Overview

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOStephen Bradley Saad BCom,

Contact Information

27 31 580 8600
Aspen Place, Durban

Company Facts

8,867 Employees
IPO DateApr 29, 2010
CountryZA
Actively Trading

Frequently Asked Questions

;